antibiotics
Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.
Breastfeeding and Bifidobacterium are key factors in shaping the infant resistome and could offer strategies to reduce antibiotic resistance early in life.
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
A healthy, diverse gut microbiota is important for mounting strong and lasting immune responses to vaccination.
The approval is major step forward in the fight against recurrent C. diff infection.
The microbiota plays a protective role against colorectal cancer by regulating Snhg9.
Chris Ford, Senior Vice President, Translational Biology at Seres Therapeutics, discusses the development of SER-155, a cultivated bacterial consortium designed to address the unmet medical need of preventing bloodstream infections…
By suggesting that the diversity and variety of microbial species play a big role in whether the transplanted microbes can successfully colonize a recipient’s gut, the findings could pave the…
The results also indicate that the hospital environment influences the gut bacteria of preterm infants, highligting the importance of managing antibiotics and medications to support a healthy gut development.
The findings improve our understanding of the genetic complexity of the human gut microbiota and its implications for health.
